Cybin Inc (NY: CYBN )
0.2550
-0.0012
(-0.47%)
Official Closing Price
Updated: 8:00 PM EDT, Aug 30, 2024
Add to My Watchlist
All News about Cybin Inc
![](https://mms.businesswire.com/media/20231120171066/en/1908939/22/Cybin_Side_Logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
Analyst Expectations for Cybin's Future
November 17, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/11/17/expedia_group_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20231116986353/en/1908939/22/Cybin_Side_Logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/11/15/dmt_investigation_rf._.studio_by_pexels_and_jynto_by_wikimedia_commons.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20231115295485/en/1908939/22/Cybin_Side_Logo.jpg)
Cybin Announces Poster Presentation at Neuroscience 2023 Annual Meeting
November 15, 2023
From Cybin Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20231114318521/en/1908939/22/Cybin_Side_Logo.jpg)
From Cybin Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20231114070772/en/1908939/22/Cybin_Side_Logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/11/12/psyched.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/11/10/financial_psychedelics_raimundo79_and_blue_planet_studio_on_shutterstock.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20231110475603/en/1908939/22/Cybin_Side_Logo.jpg)
Cybin Announces up to US$64 Million Offering of Units
November 10, 2023
From Cybin Inc.
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2023/11/06/psyched.png?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20231103920876/en/1908939/22/Cybin_Side_Logo.jpg)
From Cybin Inc.
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2023/11/01/finance_and_psychedelics_chrissmith12_bru-no_by_pixabay_1.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20231101253136/en/1908939/22/Cybin_Side_Logo.jpg)
![](https://mms.businesswire.com/media/20231031220551/en/1929735/22/Treatment_landscape.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/10/27/psyched.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/10/26/lawyer_psychedelic_cannabis_flametric_aiyoshi597_gisele_yashar_bacsica_and_freedomz_on_shutterstock.jpg?width=1200&height=800&fit=crop)
Cybin's Deuterated Psychedelics Programs Protected By Three New International Patents
October 26, 2023
Via Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
![](https://mms.businesswire.com/media/20231026710162/en/1908939/22/Cybin_Side_Logo.jpg)
Cybin Announces Grant of European Patent Protecting its Proprietary Deuterated Programs
October 26, 2023
From Cybin Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20231025315693/en/1908939/22/Cybin_Side_Logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/10/23/psychedelics_deals_geralt_sergeitokmakov_by_pixabay_1.jpg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.